Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Burnett Patrick sold 15,000 Arcutis Biotherapeutics, Inc. shares (Form 4)
Traded Aug 11 to Aug 12, 2026 · Filed Aug 13, 2026
From Aug 11 to Aug 12, 2026, Burnett Patrick (See Remarks) sold 15,000 Arcutis Biotherapeutics, Inc. shares at an average US$26.32 for US$395K, leaving 119,289 shares. Filed Aug 13, 2026 (Form 4).
- Sold
- 15,000 shares
- Price
- US$26.32 average (US$26.08 to US$26.52)
- Value
- US$395K
- Holding after
- 119,289 shares
- Trading plan
- No
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Common Stock | Option exercise | 8,300 | US$3.64 | 127,589 | Direct |
| Aug 11, 2026 | Common Stock | Sale | 8,300 | US$26.52 | 119,289 | Direct |
| Aug 12, 2026 | Common Stock | Option exercise | 6,700 | US$3.64 | 125,989 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 6,700 | US$26.08 | 119,289 | Direct |
Source
Related
- Arcutis Biotherapeutics, Inc.
- Burnett Patrick
- Arcutis Biotherapeutics, Inc. shareholders
- Form 4 · Burnett Patrick · Aug 21, 2026
- Form 4 · Burnett Patrick · Aug 5, 2026
- Form 4 · Burnett Patrick · May 13, 2026
- Form 4 · Burnett Patrick · May 6, 2026
- Form 4 · Welgus Howard G. · Oct 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 5, 2026
- Form 4 · Matsuda Masaru · Sep 18, 2026
- Form 4 · Welgus Howard G. · Sep 17, 2026
- Form 4 · Matsuda Masaru · Sep 10, 2026